Practice Management

Top Story

BLOG: Patient financing also can be used as a marketing tool

August 3, 2015

I speak with health care practices on a regular basis. During these conversations, physicians usually ask a range of questions to help determine whether they should incorporate third-party patient financing into their practice.

Here are some of the most frequently discussed topics to give a better understanding of third-party patient financing and how it can benefit practices and patients.

Josep Tabernero, MD, PhD Association News

ESMO announces 2018 2019 president

August 1, 2015
Josep Tabernero, MD, PhD, will serve as president of the European Society for Medical Oncology in 2018-2019.Tabernero is head of the medical oncology department at Vall…

AAFP, ACP join nearly 600 other organizations in support of clinical data transparency

July 31, 2015
The American Academy of Family Physicians and the American College of Physicians has announced their support of the AllTrials campaign, joining 595 other organizations…
In the Journals

Researchers successfully transport blood samples via drones

July 31, 2015
Laboratory tests performed on blood samples flown for up to 40 minutes on hobby-sized drones yielded results comparable to those performed on samples that never left the…
CME
Hematology Oncology Case Consults

Diagnosis and Management of Hemophilia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of the patient with hemophilia supplemented with a case…
More »
Meeting News Coverage Video
VIDEO: Biomarkers, checkpoint inhibitor data highlights of AACR Annual Meeting

VIDEO: Biomarkers, checkpoint inhibitor data highlights of AACR Annual Meeting

April 29, 2015
John Ebos, PhD, assistant professor of oncology in the department of cancer genetics at Roswell Park Cancer Institute…
More »
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
Blog

BLOG: Patient financing also can be used as a marketing tool

August 3, 2015
I speak with health care practices on a regular basis. During these conversations, physicians usually ask a range of questions to help determine…
Josep Tabernero, MD, PhD Association News

ESMO announces 2018 2019 president

August 1, 2015
Josep Tabernero, MD, PhD, will serve as president of the European Society for Medical Oncology in 2018-2019.Tabernero is head of the medical oncology…

AAFP, ACP join nearly 600 other organizations in support of clinical data transparency

July 31, 2015
The American Academy of Family Physicians and the American College of Physicians has announced their support of the AllTrials campaign, joining 595…
In the Journals

Researchers successfully transport blood samples via drones

July 31, 2015
Laboratory tests performed on blood samples flown for up to 40 minutes on hobby-sized drones yielded results comparable to those performed on samples…
Charis Eng, MD, PhD In the Journals

Risk calculator an accurate, cost-effective prescreening tool for PTEN mutations

July 30, 2015
The PTEN Cleveland Clinic score appeared to be a cost-effective prescreening tool to identify patients with Cowden-like disease who are appropriate…
In the JournalsPerspective

Health care spending expected to increase over decade, but at historically low rate

July 29, 2015
Due to expanded health insurance coverage from the ACA, as well as the aging population and economic growth, health care spending is projected to…
In the Journals

Oncologists criticize high drug costs, propose cost-cutting measures

July 28, 2015
Over 100 U.S. oncologists have issued a statement deriding the high cost of cancer drugs and calling for new regulations to mitigate expenses.Authors…
In the Journals

Ethanol locks reduce central venous catheter-associated bloodstream infections in children with cancer

July 27, 2015
Ethanol locks prevented central venous catheter-associated bloodstream infections in pediatric patients with cancer, according to the results of a…
In the Journals

Reporting of serious AEs to FDA often delayed by drug companies

July 27, 2015
Nearly 10% of adverse events are not reported to the FDA within the 15-day period drug companies have to disclose the events, according to recently…
VIDEO: Immunotherapy, combination therapy emerge as key ASCO themes Meeting News CoverageVideo

VIDEO: Immunotherapy, combination therapy emerge as key ASCO themes

July 27, 2015
CHICAGO — John Sweetenham, MD, FRCP, FACP, and Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, HemOnc Today’s Chief Medical Editors…
More Headlines »